Healthcare
MSPEA makes another partial exit from Sihuan Pharma
Morgan Stanley Private Equity Asia (MSPEA) has made another partial exit from Hong Kong-listed Sihuan Pharmaceuticals, generating up to HK$1.12 billion ($145 million) through a block trade.
EQT scans I-Med opportunity
When EQT made its first move to acquire Australian radiology provider I-Med, the first challenge was to build trust with the company’s management. The business had already been through a number of financial investors’ hands and it had not been an altogether...
KKR completes Panasonic Healthcare deal, eyes bolt-ons
KKR has completed the acquisition of an 80% stake in Panasonic Healthcare, its biggest buyout in Japan to date. According to a source familiar with the situation, operations unit KKR Capstone is already working with the company and a number of bolt-on...
Rabo Equity invests in Indian biotech firm
Rabo Equity Advisors' India Agribusiness Fund has invested INR750 million ($13 million) in Beloorbayir Biotech, a Bangalore-based drug developer.
China Aier Eye Hospital invests in Huatai Securities' M&A fund
Shenzhen-listed Aier Eye Hospital Group plans to commit RMB100 million ($16 million) to an M&A fund managed by Huatai United Securities, an investment banking arm of Huatai Securities.
China health data start-up secures $2m angel round
China health data mobile app provider 37 Health has secured a RMB10 million ($2 million) seed funding round led by Broadhi Capital.
NewQuest, GIC set for partial exits from China's iKang
NewQuest Capital Partners and GIC Private will each make partial exits from iKang Healthcare Group as the Chinese healthcare services provider looks to raise up to $175 million through a NASDAQ IPO.
EQT confirms acquisition of Australia's I-Med
EQT Partners has confirmed its acquisition of Australian radiology provider I-Med Network Radiology alongside Caisse de dépôt et placement du Québec of Canada and Singapore's GIC Private.
ChrysCapital invests $20m in India's Torrent Pharma - report
ChrysCapital is said to have acquired a stake in Ahmedabad-based drug company Torrent Pharmaceuticals for around INR1.2 billion ($19 million).
India's Persistent backs hand hygiene wearables start-up
Persistent Venture Fund, a VC fund controlled by listed Indian software and technology company Persistent Systems, has invested in Hyginex, a US-based wearable technology manufacturer specializing in healthcare applications.
General Atlantic invests in India's CitiusTech
General Atlantic has invested in Indian healthcare technology services firm CitiusTech. Financial details were not disclosed but GA is understood to have paid around $110 million for a significant minority stake.
China Aier Eye Hospital invests in Qianhai M&A fund
Shenzhen-listed Aier Eye Hospital Group has launched an M&A fund with China Orient Asset Management with a view to bringing about consolidation in the ophthalmology industry.
China's Hainan Haiyao to invest $20m in pharma-focused JV
China’s Hainan Haiyao, a Shenzhen-listed drug maker and distributor, plans to invest RMB122 million ($20 million) in a pharma-focused joint venture with several venture capital firms.
PE-backed China iKang Healthcare files for $150m US IPO
IKang Healthcare Group - the Chinese healthcare services provider whose backers include Singapore sovereign wealth fund GIC Private, Goldman Sachs and NewQuest Asia - is planning to raise up to $150 million in an initial public offering on NASDAQ.
Bayer buys Legend Capital-backed Dihon Pharma
Bayer has agreed to buy Dihon Pharmaceutical Group, a manufacturer of herbal traditional Chinese medicines (TCM). The acquisition facilitates the exit of Legend Capital, an investor in Dihon since 2010.
EQT buys restructured I-Med from hedge fund owners
Australian radiology provider I-Med Network Radiology is being sold by its hedge fund owners to a consortium led by EQT Partners.
Bamboo Finance, Saama Capital invest in India's Modern Family Doctor
Bamboo Finance, a European private equity firm that focuses on investments benefiting low-income communities in emerging markets, and early stage investor Saama Capital have together taken part in a Series B round of funding for Indian healthcare provider...
CITIC PE considers Biosensors acquisition – update
CITIC Private Equity has held talks about potentially increasing its stake in Singapore-listed portfolio company Biosensors International, the medical device maker said on Wednesday.
CITIC PE to buy medical devices firm Biosensors - report
CITIC Private Equity is said to be looking to buy full control of its Singapore-listed portfolio company Biosensors International, a medical device maker.
TPG, Fosun set for $369m China healthcare take-private
TPG Capital and Fosun Industrial have teamed up with the CEO of Chinese healthcare provider Chindex International have won board approval to privatize the NASDAQ-listed company. The deal values Chindex at approximately $369 million.
JAIC, Nippon Venture lead Series D for Regimmune
Japan Asian Investment Corporation (JAIC) and Nippon Venture Capital have together led a $9.2 million Series D round of investment in Tokyo-based biotech firm Regimmune Corporation.
India impact investments total $390m in 2013 - Unitus
Private equity impact investments in India totaled $390 million across 80 deals last year – comprising 23% of all PE transactions in the country - says Bangalore-based financial advisor Unitus Capital.
Jafco-backed Eleven Bio raises $50m in NASDAQ IPO
Eleven Biotherapeutics, a US biopharma company firm backed by Japan’s Jafco Ventures, has raised $50 million through its NASDAQ IPO – short of the $69 million initially sought.
Portfolio: STIC Investments and Access Bio
STIC Investments backed Access Bio when the Korean-led malaria testing technology player wanted to buy key components and expand output. Now KOSDAQ-listed, the company has its eye on specialty diagnostics